Dec 23, 2024 11:11AM

Dec 17, 2024 04:12PM

Dec 6, 2024 08:34AM

Nov 4, 2024 08:00AM

Sep 11, 2024 05:41PM

Sep 3, 2024 09:44PM

Aug 14, 2024 07:38AM Form SC 13D/A AIM ImmunoTech Inc. Filed by: Deutsch Todd

Jul 30, 2024 07:15AM

Jul 15, 2024 05:20PM

Jan 3, 2024 04:25PM

Aug 28, 2023 06:37AM

Aug 7, 2023 04:16PM

Jul 27, 2023 05:02PM

Sep 28, 2021 09:20AM AIM ImmunoTech (AIM) Submits Pre-IND Application to the FDA for Phase 2 Clinical Studies of Ampligen as a Potential Early-Onset Therapeutic for COVID-19

69,977 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All